Pregled bibliografske jedinice broj: 1197773
Morbihan disease – An old and rare entity still difficult to treat
Morbihan disease – An old and rare entity still difficult to treat // Acta Dermatovenerologica Croatica, 28 (2020), 2; 118-119 (međunarodna recenzija, pismo uredniku, stručni)
CROSBI ID: 1197773 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Morbihan disease – An old and rare entity still difficult to treat
(Morbihan disease – An old and rare entity still
difficult to treat)
Autori
Jerković Gulin, Sandra ; Ljubojević Hadžavdić, Suzana
Izvornik
Acta Dermatovenerologica Croatica (1330-027X) 28
(2020), 2;
118-119
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo uredniku, stručni
Ključne riječi
Morbihan disease ; diagnosis ; treatment
Sažetak
Morbihan disease (MD), also known as Morbihan syndrome, "solid persistent facial edema and erythema", "rosacea lymphedema", and "solid facial edema in acne", is a rare and often unrecognizable entity, that presents with a slow occurrence of persistent lymphoedema of the upper two-thirds of the face. A 30-year-old woman presented to our Department with persistent, asymptomatic face edema and erythema lasting for 18 months. She was previously treated for rosacea with doxycycline (100 mg/day for four months) without improvement. Dermatological examination revealed erythematous, nonpitting, solid edema located on the mid-forehead, nose, and cheeks with sparse erythematous papules and pustules on the entire face including the chin and comedones, papules, and pustules on the back. Based on the typical clinical picture, histopathological findings, and the exclusion of several differentials the diagnosis of MD was established. The patient was treated with oral isotretinoin (20 mg/day for eight months) without regression of solid edema and erythema on the face but with complete regression of acne on the trunk. She was started on oral corticosteroids (prednisolone, 20 mg/day for two months followed by reduction of the dose over three months), again with only slight short transient improvement and rapid relapse of facial erythema and edema. The patient refused any other suggested treatment. We treated our patient for a total 2 years and followed up for 5 years. The pathogenesis of MD is still unknown. It is believed that chronic inflammation in patients with MD is due to acne or rosacea causing structural damage to blood and lymph vessels. We presented a patient with characteristic features of MD, which is a persistent, cosmetically disturbing condition, unfortunately mostly refractory to therapeutic measures.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Opća bolnica Šibenik,
Klinički bolnički centar Zagreb
Profili:
Suzana Ljubojević Hadžavdić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE